Credit: Wellcome Trust Sanger Institute The Deciphering Developmental Disorders (DDD) project aims to provide diagnoses for the families of around
Continue reading »
mypharmacynews.com
Credit: Wellcome Trust Sanger Institute The Deciphering Developmental Disorders (DDD) project aims to provide diagnoses for the families of around
Continue reading »The Endocrine Society today issued a Clinical Practice Guideline advising healthcare providers on how to diagnose and treat the endocrine
Continue reading »BOSTON, June 14, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization
Continue reading »Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an
Continue reading »Biological Psychiatry has published a new study revising the outdated estimates of the prevalence of eating disorders in the United
Continue reading »Largest study to date shows that disrupted body clock rhythms are associated with increased susceptibility to depression, bipolar disorder, and
Continue reading »(HealthDay)—Substance use disorders are associated with conversion from schizotypal disorder to schizophrenia, according to a study published online April 25
Continue reading »